Results 21 to 30 of about 800 (149)

A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination. [PDF]

Turk J Ophthalmol, 2023
We present a 65-year-old woman who developed sudden and severe vision loss in her left eye one day after the administration of the second dose of coronavirus disease-19 vaccine. The best corrected visual acuity in this eye was 1/10.
Menteş J, Nalçacı S, Değirmenci C.
europepmc   +2 more sources

Acute macular neuroretinopathy and COVID-19 or SARS-CoV-2 infection: case report and literature review. [PDF]

Front Med (Lausanne)
PurposeTo describe a case of acute macular neuroretinopathy (AMN) associated with COVID-19 infection and a related literature review.MethodsA case from the First Affiliated Hospital of Chongqing Medical University was reported that could be linked to ...
Wang X, Wang P, Lu J, Ju H, Xie H, Peng H.   +5 more
europepmc   +2 more sources

Acute macular neuroretinopathy (literature review) [PDF]

Russian Journal of Clinical Ophthalmology
The review is focused on an orphan disease of the central retina — acute macular neuroretinopathy ( AMN). For the first time, AMN was described by P.J. Bos and A.F. Deutman in 1975. In 2011, S. Yeh et al. proposed a term "acute macular outer retinopathy". In 2013, owing to optical coherence tomography of the retina, D. Sarraf et al.
R.S. Zhazybaev, E.L. Sorokin
openaire   +2 more sources

Acute macular neuroretinopathy: clinical cases

Journal of Clinical Practice
BACKGROUND: Acute macular neuroretinopathy is a rare disease of the central retinal zone. CLINICAL CASES DESCRIPTION: The first clinical case represents a male patient aged 47 years with the complaints of a decreased vision acuity and developing a spot in the vision fields of the left eye. He was treated at the ophthalmology clinic due to acute central
Ruslan S. Zhazybaev, Evgenii L. Sorokin, Arkadiy L. Zhirov, Oleg V. Danilov   +3 more
openaire   +3 more sources

The characteristics of acute macular neuroretinopathy following COVID-19 infection. [PDF]

BMC Ophthalmol
Background In this study, we report a case series of acute macular neuroretinopathy (AMN) associated with COVID-19 infection. Methods This retrospective observational study was conducted at Beijing Tongren Hospital.
Feng H, Zhao M, Mo J, Cao X, Chen W, Wang H.   +5 more
europepmc   +2 more sources

Recurrence of Acute Macular Neuroretinopathy [PDF]

Ophthalmic Surgery, Lasers and Imaging Retina, 2018
A 31-year-old female with a 2-month history of a central scotoma was diagnosed with acute macular neuroretinopathy (AMNR). Her symptoms resolved spontaneously, only to recur 2 years later with progressively worsening visual field deficits that did not improve with a trial of oral prednisone.
Amber, Hoang, Kay T, Khine, Odette M, Houghton   +2 more
  +15 more sources

Acute Macular Neuroretinopathy and Coronavirus Disease 2019. [PDF]

Ophthalmol Retina, 2023
Dinh RH, Tsui E, Wieder MS, Barash A, Park MM, Rahimy E, Mruthyunjaya P, Lu LJ, Michalak SM, Shah RJ, Sierpina D, Winter TW, Shields RA, Uchiyama E, Lee GD, Komati R, Lee E, Kasi SK, Do BK.   +18 more
europepmc   +3 more sources

Acute macular neuroretinopathy [PDF]

Clinical and Experimental Optometry, 2003
Acute macular neuroretinopathy is an infrequently encountered condition in which there is a sudden mild central vision loss, photopsia and red-brown wedge-shaped lesions in the macular region with corresponding scotomata in the central visual fields. The condition may be associated with the use of oral contraceptives or with a recent febrile illness ...
Ian S, Douglas, David M, Cockburn
openaire   +3 more sources

Bilateral acute macular neuroretinopathy in a young woman after the first dose of Oxford–AstraZeneca COVID-19 vaccine

American Journal of Ophthalmology Case Reports, 2022
Purpose: To report a case of bilateral acute macular neuroretinopathy following the first dose of Oxford-AstraZeneca COVID-19 (coronavirus disease 2019) vaccine in a young, Caucasian, and healthy woman.
Pierre-Henry Gabrielle, Florian Baudin, Ines Ben Ghezala, Cyril Meillon, Alain Marie Bron, Louis Arnould, Catherine Creuzot-Garcher   +6 more
doaj   +1 more source

Recurring nodular scleritis following inactivated vaccination for COVID‐19

Clinical Case Reports, Volume 11, Issue 6, June 2023., 2023
Key Clinical Message Though COVID‐19 vaccination saved many lives all around the world, it has had many adverse effects including ophthalmologic side effects. It is important to report such adverse effects to provide timely diagnosis and management. Abstract Since the COVID‐19 global outbreak, many types of vaccines have been introduced. These vaccines
Alireza Peyman, Mohsen Pourazizi, Shakiba Dehghani, Sarah Ghorbani   +3 more
wiley   +1 more source